Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.31 |
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.30 |
| ▸ | ADRA1A known ✓ | P35348 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | SLC13A5 | Q86YT5 | 3/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HMGCR | P04035 | 1/20 | 0.30 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL29280332 | 0.98 | ALDH1A1 (0.56) | ALDH1A1KDM4ELMNAMAPTALOX15 | |
| Water SCHEMBL2345209 | 0.98 | ALDH1A1 (0.56) | ALDH1A1KDM4ELMNAMAPTALOX15 | |
| Water SCHEMBL6861649 | 0.98 | ALDH1A1 (0.56) | ALDH1A1KDM4ELMNAMAPTALOX15 | |
| Water SCHEMBL19925293 | 0.98 | ALDH1A1 (0.56) | ALDH1A1KDM4ELMNAMAPTALOX15 | |
| Water SCHEMBL8440717 | 0.98 | ALDH1A1 (0.56) | ALDH1A1KDM4ELMNAMAPTALOX15 | |
| Water SCHEMBL8401316 | 0.98 | ALDH1A1 (0.56) | ALDH1A1KDM4ELMNAMAPTALOX15 | |
| SCHEMBL10561448 | 0.98 | ALDH1A1 (0.56) | ALDH1A1KDM4ELMNAMAPTALOX15 | |
| Water SCHEMBL789158 | 0.98 | ALDH1A1 (0.56) | ALDH1A1KDM4ELMNAMAPTALOX15 | |
| Water SCHEMBL953536 | 0.98 | ALDH1A1 (0.56) | ALDH1A1KDM4ELMNAMAPTALOX15 | |
| Water SCHEMBL29234698 | 0.98 | ALDH1A1 (0.56) | ALDH1A1KDM4ELMNAMAPTALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3527211-B1 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OR REMISSION OF CHRONIC MYELOGENOUS LEUKEMIA | DELTA FLY PHARMA INC (JP) | 2023-08-23 | — | — | EP | disclosed |
| CN-115315258-A | Renal function protective agent | 国立大学法人东北大学 | 2022-11-08 | — | — | CN | disclosed |
| EP-4008346-A1 | AGENT FOR ENHANCING EFFECT OF ANTICANCER AGENT | Delta-Fly Pharma, Inc. (JP) | 2022-06-08 | — | — | EP | disclosed |
| US-11246847-B2 | Anticancer drug effect enhancer | DELTA-FLY PHARMA, INC. (JP) | 2022-02-15 | — | — | US | disclosed |
| US-11185517-B2 | Pharmaceutical composition for treatment or remission of chronic myelogenous leukemia | DELTA-FLY PHARMA, INC. (JP) | 2021-11-30 | — | — | US | disclosed |
| US-20210228517-A1 | ANTICANCER DRUG EFFECT ENHANCER | DELTA-FLY PHARMA, INC. (JP) | 2021-07-29 | — | — | US | disclosed |
| CN-112888434-A | Novel pharmaceutical composition | 国立大学法人东北大学 | 2021-06-01 | — | — | CN | disclosed |
| CN-112839678-A | Potentiator of anticancer agent effect | 德尔塔菲制药股份有限公司 | 2021-05-25 | — | — | CN | disclosed |
| US-20200078322-A1 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OR REMISSION OF CHRONIC MYELOGENOUS LEUKEMIA | DELTA-FLY PHARMA, INC. (JP) | 2020-03-12 | — | — | US | disclosed |
| CN-110799214-A | Blood purification with alkalizer | 国立大学法人东北大学 | 2020-02-14 | — | — | CN | disclosed |
| EP-3527211-A1 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OR REMISSION OF CHRONIC MYELOGENOUS LEUKEMIA | Delta-Fly Pharma, Inc. (JP) | 2019-08-21 | — | — | EP | disclosed |
| US-20190247338-A1 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OR REMISSION OF CHRONIC MYELOGENOUS LEUKEMIA | DELTA-FLY PHARMA, INC. (JP) | 2019-08-15 | — | — | US | disclosed |